Related Experiment Video
Updated: May 27, 2026
05:46
Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile
Published on: September 20, 2024
Intraocular lenses for presbyopia correction: past, present, and future
Alejandro Lichtinger1, David S Rootman
1Department of Ophthalmology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
Current Opinion in Ophthalmology
|November 15, 2011
Summary
Presbyopia-correcting intraocular lenses (IOLs) have evolved significantly, but challenges like glare and visual disturbances persist. Careful patient selection is key for successful outcomes with current multifocal and accommodating IOLs.
Area of Science:
- Ophthalmology
- Biomedical Engineering
Background:
- Presbyopia correction using intraocular lenses (IOLs) has been a focus for decades.
- Early IOLs offered limited visual correction and potential side effects.
Purpose of the Study:
- To review the evolution of presbyopia-correcting IOLs.
- To discuss current market options and future technological advancements.
- To highlight challenges and considerations in IOL technology.
Main Methods:
- Review of historical development of presbyopia-correcting IOLs.
- Analysis of current multifocal and accommodating IOLs.
- Exploration of emerging IOL technologies.
Main Results:
- Modern multifocal and accommodating IOLs show improved visual outcomes but are not perfect.
- Side effects like glare, halos, and inconsistent near vision remain concerns.
- Patient selection is critical for optimizing satisfaction with current IOLs.
Conclusions:
- Presbyopia correction remains a significant challenge in ophthalmic surgery.
- Current IOLs represent advancements but require careful consideration of patient needs.
- Future IOL developments aim to further refine visual quality and minimize side effects.
Related Concept Videos
01:16Focusing of Light in the Eye
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...